Oticon Medical
Clinical trials sponsored by Oticon Medical, explained in plain language.
Hearing implant manufacturer, part of the Demant group.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hearing implant trial aims to help kids hear better Results expected Oct 2026 (estimated)
- Which bone conduction hearing device works best? new study aims to find out. Results expected Oct 2026 (estimated)
- Hearing implants without the OR: a safer, simpler approach? Results expected Mar 2027 (estimated)
- New hearing device for teens: can it restore sound? Results expected Apr 2027 (estimated)
-
Which bone conduction hearing device works best? new study aims to find out.
Knowledge-focused Not yet recruitingThis study will compare four different non-surgical bone conduction hearing devices in 20 adults aged 18 to 84 with mixed or conductive hearing loss. The goal is to see which device provides the best hearing improvement by measuring hearing thresholds. The results could help guid…
Sponsor: Oticon Medical • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New hearing implant sentio under study: could it help the deaf hear?
Knowledge-focused Not yet recruitingThis study will observe 100 adults who receive the Sentio bone conduction hearing system as part of their normal care. The device is implanted under the skin and sends sound vibrations through the skull to the inner ear. Researchers will track how often the device is used success…
Sponsor: Oticon Medical • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:39 UTC